$IMA

ImageneBio, Inc.

No enriched coverage for $IMA in the last 7 days.

No SEC Form 4 filings for $IMA in the last 30 days.

Low

How Ikena Oncology Inc. stock reacts to Fed rate cuts - July 2025 Highlights & Long-Term Capital Growth Strategies

This article, initially titled to discuss Ikena Oncology Inc. stock performance related to Fed rate cuts, appears to be a clickbait or erroneous publication. The content within the article primarily details a report about a swimming accident involving a pleasure boat in Tai Po, leading to a man's death and the captain's arrest. It also briefly mentions a disconnected report about a birth certificate verification.

HUTCHMED Reports 2025 Interim Results - HUTCHMED ( China ) ( NASDAQ:HCM )

- Indications expansion driving growth and ATTC platform enriching pipeline - - $455 million in net income attributable to HUTCHMED driven by non-core partial disposal - HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- HUTCHMED ( China ) Limited ( "HUTCHMED", ...